Quince Therapeutics, Inc. (NasdaqGS:QNCX) announced that it has retained MTS Health Partners, L.P. as its financial advisor to support Quince's Board of Directors and management team in the review and evaluation of strategic alternatives intended to maximize long-term value for all Quince stockholders. The engagement will focus on the company's previously stated prioritization of in-licensing and acquisition activities, as well as alternative options and proposals, as warranted.